Samuel L. Schach

Researcher

Last publication 2026 Last refreshed 2026-05-02

unknown

4 pubs

Biography and Research Information

OverviewAI-generated summary

Samuel L. Schach's research focuses on understanding and developing new therapeutic strategies for cancer, particularly exploring the potential of immune checkpoint inhibitors (ICI) and targeting molecular pathways like K-ras/p53 for synthetic lethality. His work also addresses the concept of "Off-the-Shelf Therapeutic Overactivation (TOA)," suggesting a need for improved therapeutic control. Schach has authored a total of four publications and collaborates with researchers at the University of Arkansas for Medical Sciences, including Ahmad Mazin M. Safar and Liyan Mazahreh, with whom he shares multiple publications. His research is characterized by its recent activity and engagement with emerging concepts in oncology.

Metrics

  • Publications: 4

Selected Publications

  • Cancer and all-cause mortality among United States union poultry workers (2026)
  • Abstract 3214: The duration of immune checkpoint inhibitors (ICI) in oncology: Longer is not better (2025)
  • Abstract 5582: Interrogating the K-ras/p53 transcriptional readout for synthetic lethality applications (2025)

View all publications on OpenAlex →

Collaboration Network

4 Collaborators 1 Institution 1 Country

Top Collaborators

View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics